We have not yet seen a vigorous lean into this test, despite how massively important

they could be.

That's Dr. Michael Minna.

He's an epidemiologist and immunologist and a physician at Harvard.

You could say he's a man with many hats and lately he's been a vocal advocate for widespread,

rapid, COVID testing.

Test that could be done at home in his littlest five minutes.

These tools have so much promise and people are going to have this next to their kitchen

sink or next to their bathroom sink.

And if your kid has a fever, you don't have to bring him to the doctor.

You just pull out a little tube that says, hey, check if it's flu RSV or COVID and you swab

their nose or their cheek and you stick it in the box here and a few minutes later

you know what your kid's sick with.

To hear Dr. Minna describe it, these tests sound amazingly simple and amazingly useful.

Maybe even game changing in terms of helping control the spread of COVID in the United States.

I really think that COVID is serving as a catalyst here for a shaving 10 years off of the

development of these tests to get them into the homes today so that you know by 2022 I

think we should all expect really the diagnostic landscape to look quite different.

For today's episode, I talked to Dr. Minna about our country's current testing strategy.

The difference between testing to diagnose versus testing for public health and what we

can do to raise our testing game in the United States to the next level.

I'm Dr. Sanjay Gupta, CNN's Chief Medical Correspondent and this is coronavirus, fact versus fiction.

...